Welcome to Skin cancer and Mesothelioma Cancer

Mesothelioma Cancer, Melanoma Cancer, Mesothelioma, Mesothelioma Lawyer
==================================================================

Sunday, July 20, 2008

Fwd: Influence of hospital and surgeon volumes on operative time, blood loss and perioperative complications in radical nephrectomy.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: Influence of hospital and surgeon volumes on operative time, blood loss and perioperative complications in radical nephrectomy.
To: mesothelioma77@gmail.com


[1]Int J Urol. 2008 Jul 10;
Yasunaga H, Yanaihara H, Fuji K, Matsuyama Y, Deguchi N, Ohe K

Objectives: We conducted a nationwide multi-center survey using medical record-based data to investigate the relationship between hospital/surgeon volumes and various outcomes, including operative time, volume of blood loss, and incidence of perioperative complications, in radical nephrectomy for renal cell carcinoma. Methods: We investigated a total of 1704 patients who underwent radical nephrectomy at 461 hospitals in Japan between November 2006 and February 2007. The association between hospital/surgeon volumes and operative time, volume of blood loss, and incidence of perioperative complications were independently analyzed using multivariate regression analysis against age, gender, operation site, cancer stage, serum creatinine levels, comorbid conditions, and surgical technique (open surgery or minimally invasive surgery). Results: Neither hospital volume nor surgeon volume was a significant predictor of operative time or volume of blood loss. We did not identify any association between hospital volume and perioperative complications. High-volume (> 100) surgeons were unlikely to have perioperative complications compared to low-volume (

___
Source: http://www.hubmed.org/display.cgi?uids=18637158
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Risk prediction models with incomplete data with application to prediction of estrogen receptor positive breast cancer: prospective data from the Nurses' Health Study



---------- Forwarded message ----------
From: Connotea: Bookmarks matching tags breast and cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: Risk prediction models with incomplete data with application to prediction of estrogen receptor positive breast cancer: prospective data from the Nurses' Health Study
To: mesothelioma77@gmail.com


[1]

[2]Risk prediction models with incomplete data with application to prediction of estrogen receptor positive breast cancer: prospective data from the Nurses' Health Study

Bernard Rosner et al.

Breast Cancer Research 10 (4), R55 (03 Jul 2008)

info:doi/10.1186/bcr2110

Posted by [3]jls1948 to [4]estradiol [5]breast [6]prediction [7]Markers [8]cancer on [9]Wed Jul 16 2008 at 14:40 UTC | [10]info | related

jls1948

___
Source: http://www.connotea.org/user/jls1948/uri/6d435688f689048c3352733103d720fe
--
 ~
Powered by [14]RssFwd, a service of [15]Blue Sky Factory, Inc

 

Fwd: Bilateral synchronous breast cancer in a male.



---------- Forwarded message ----------
From: Connotea: Bookmarks matching tags breast and cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: Bilateral synchronous breast cancer in a male.
To: mesothelioma77@gmail.com


[1]

[2]Bilateral synchronous breast cancer in a male.

Peter B Kahla et al.

The Mount Sinai journal of medicine, New York 72 (2), 120-3 (Mar 2005)

info:pmid/15770342

Posted by [3]mjpires to [4]synchonous [5]sentinel lymph node [6]bilateral [7]breast [8]Male [9]cancer on [10]Thu Jul 17 2008 at 18:52 UTC | [11]info | related

mjpires

___
Source: http://www.connotea.org/user/mjpires/uri/95bccd3159b3bced492875d02ab92a48
--
 Powered by [15]RssFwd, a service of [16]Blue Sky Factory, Inc

 

Fwd: The use of complementary therapy by men with prostate cancer in the UK.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: The use of complementary therapy by men with prostate cancer in the UK.
To: mesothelioma77@gmail.com


[1]Eur J Cancer Care (Engl). 2008 Jul 7;
Wilkinson S, Farrelly S, Low J, Chakraborty A, Williams R, Wilkinson S

The study aims were to determine the use of complementary therapies (CT) by men with prostate cancer, and to explore factors influencing CT use and attitudes toward CT use. A cross-sectional survey design was used in which a postal questionnaire was mailed to an eligible sample of 405 patients with prostate cancer receiving outpatient treatment in a London teaching hospital. The primary outcomes were the prevalence of CT use and the relationship between CT use and mental health status. Two hundred and ninety-four patients (73%) responded, of whom 25% were using CT. The most frequently used CTs were vitamins, low-fat diets, lycopene and green tea. Multivariate analyses revealed no differences in mental health scores between CT users and non-users. CT users were younger (OR 0.93, 95% CI 0.89-0.97) and were more likely to be receiving conservative management in the form of 'active surveillance' (OR 5.23, 95% CI 1.78-15.41) compared with non-users. Over half of the participants (55%) wanted to learn more about CT. Forty-three per cent of CT users had not informed any doctor about their CT use. Clinicians need to be aware of the prevalence of CT use amongst patients with prostate cancer, considering the potential harm that could be caused by interactions with conventional treatments.



___
Source: http://www.hubmed.org/display.cgi?uids=18637112
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Mechanism for gastric cancer development by Helicobacter pylori infection.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: Mechanism for gastric cancer development by Helicobacter pylori infection.
To: mesothelioma77@gmail.com


[1]J Gastroenterol Hepatol. 2008 Jun 10;
Chiba T, Marusawa H, Seno H, Watanabe N

Helicobacter pylori (H. pylori) infection plays a crucial role in the development of gastric cancer. There are two major pathways for the development of gastric cancer by H. pylori infection: the indirect action of H. pylori on gastric epithelial cells through inflammation, and the direct action of the bacteria on epithelial cells through the induction of protein modulation and gene mutation. Both pathways work together to promote gastric carcinogenesis.



___
Source: http://www.hubmed.org/display.cgi?uids=18637055
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Canadian academics call for asbestos report to be published.



---------- Forwarded message ----------
From: HubMed - asbestos cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: Canadian academics call for asbestos report to be published.
To: mesothelioma77@gmail.com


[1]BMJ. 2008 Jun 7; 336(7656): 1269
Spurgeon D





___
Source: http://www.hubmed.org/display.cgi?uids=18535052
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Risk of Development of Lung Cancer Is Increased in Patients with Rheumatoid Arthritis: A Large Case Control Study in US Veterans.



---------- Forwarded message ----------
From: HubMed - asbestos cancer <rssfwd@rssfwd.com>
Date: Sat, Jul 19, 2008 at 9:37 PM
Subject: Risk of Development of Lung Cancer Is Increased in Patients with Rheumatoid Arthritis: A Large Case Control Study in US Veterans.
To: mesothelioma77@gmail.com


[1]J Rheumatol. 2008 Jul 15;
Khurana R, Wolf R, Berney S, Caldito G, Hayat S, Berney SM

OBJECTIVE: To investigate the occurrence of lung cancer in patients with rheumatoid arthritis (RA) in the US veteran population. Patients with rheumatic diseases appear to have an increased risk for the development of lymphoproliferative and some solid organ malignancies. METHODS: We conducted a retrospective case control study using prospectively collected data from the Veterans Integrated Service Networks (VISN) 16 Veteran Affairs (VA) database from 1998 to 2004. We studied the association of RA and lung cancer and analyzed data on 483,721 VA patients. Patients were identified by searching for the diagnoses of RA and lung cancer based on the International Classification of Diseases (ICD) codes. We identified 8768 (1.81%) patients with a diagnosis of RA (ICD code 714.0), 7280 (1.5%) patients with lung cancer (ICD code 162.0), 247 patients with lung cancer and RA, and 7033 patients with lung cancer but no RA. Logistic regression analysis was performed to adjust for age, gender, race, and tobacco and asbestos exposure. Statistical tests were conducted at a 5% level of significance. RESULTS: The diagnosis of RA was determined to have a significant association with lung cancer in this veteran population. Patients with RA are 43% (odds ratio 1.43) more likely to develop lung cancer than patients without RA, when adjusted for covariates. CONCLUSION: Our study shows a significant positive association between RA and the development of lung cancer in the veteran population. Veterans with RA have an increased incidence of lung cancer when compared to the non-RA population.



___
Source: http://www.hubmed.org/display.cgi?uids=18634160
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc